Jadomycins are anticancer antibiotics isolated from Streptomyces venezuelae. The core of these natural products consists of a dihydro-phenanthridine ring-system. Another unique feature built to the core is a fused 1,3-oxazolidine-5-one ring. Recent synthetic reports suggest a structural revision of the fused oxazolidinone ring in jadomycin S and jadomycin T. This review will focus on the synthetic efforts leading to the structural revision, and the semisynthetic approaches to generate new jadomycin analogs and their biological activity.
Introduction:
Jadomycins are secondary metabolites produced by Streptomyces venezuelae ISP5230 under environmental stress. 1, 2 These polyketide natural products contain an unusual 8H-benzo [b] phenanthridine backbone with variously fused nitrogen and oxygen containing heterocycles (e.g., oxazolidine, oxazinane and pyrimidine). All jadomycins are glycosylated with -L-digitoxose sugar unit except jadomycin A. 3 This carbohydrate moiety is known to improve the biological activity of the natural product. 4 Jadomycins exhibit anticancer activity and are also active against Gram positive and Gram negative bacteria. 5 The unique structural features coupled with impressive biological activities has rendered interest in their synthesis and biological evaluation. A review on biosynthetic pathway and first total synthesis of jadomycin A has been reported earlier. 6 In the following sections, recent efforts toward total synthesis as well as the semi-synthetic approaches for new analog synthesis and their biological activities are discussed.
Synthetic Approaches:
In 2010, Ishikawa group reported the synthesis of dimethyljadomycin A. 7 Their approach utilizes -spirolactonyltetralone 4 as a key intermediate for the synthesis of phenanthridine ring system. Benzylic bromination of 4 followed by bromide displacement with hydroxide and a subsequent oxidation formed quinone 5 (Scheme 1). Treatment of 5 with methylamine followed by thermal dehydration was used to construct the phenanthridine ring on a model substrate. 7 However, no cyclization was observed when methylamine was substituted with isoleucine methyl ester 6 (Scheme 1).
Scheme 1: Spirolactone as key intermediate
Successful construction of the jadomycin ringsystem was achieved by employing an oxidative cyclization. Toward this end, the carboxylate moiety on 7 was converted to an aldehyde by sequential reduction/oxidation. This aldehyde then cyclizes with the carboxylic acid moiety of isoleucine in 10 which give rise to the pentacyclic jadomycin ring-system 11. Unfortunately, any attempt to de-methylate 11 remained unsuccessful (Scheme 2). The sensitivity of the oxazolidone ring resulted in complex mixture during de-methylation thus jadomycin A was not accessible through this route. The first step in the sequence is incorporation of tryptophan on to the aglycon 14, which occurs smoothly however, successive oxidative cyclization was problematic. 8 Use of N-Boc protected tryptophan gave the desired product 21 in good yield (Scheme 4).
Scheme 4: Synthesis of analogs
Next they attempted the synthesis of jadomycin S aglycon. Following their optimized synthetic route (amino acid incorporation/oxidative cyclization), pentacyclic jadomycin ring 23 was synthesized. However, during deprotection of the primary alcohol and the MOM group they observed rearrangement of 1,3-oxazolidin-5-one ring in 23a to 1,3-oxazolidine-4-carboxylic acid 23c. This rearrangement presumably proceeds through ring-opened isoquinolinium 23b. The more nucleophilic primary alcohol preferentially cyclizes with the iminium 23b (Scheme 5). The carboxylic acid intermediate 23c was further esterified to 24 for structure elucidation. Based on this observation in the aglycon synthesis, they invoked a structural revision in jadomycin S and jadomycin T both of which are derived from a hydroxy containing amino acid.
Scheme 5: Plausible rearrangement of oxazolidone ring
In 2010, O'Doherty and coworker reported the first synthesis of jadomycin A and a carbasugar analog of jadomycin B. 9 They designed a biomimetic approach, in which the amino acid is introduced into the molecule through an aldehyde intermediate 28. The key step in their synthesis is a 6--electrocyclic ring closure of 27 to form the hydrated phenanthridine ring 26. A subsequent acid catalyzed oxazolidone ring formation gives the pentacyclic ring-system of jadomycin (Scheme 6). 6, 9, 10 Scheme 6: Retrosynthesis
The synthesis involved a Stille crosscoupling between stannane 30 and bromojuglone 31 to form 32 which after acetal deprotection gives the aldehyde 33. 11 Initial efforts for cyclization involved using fully protected 33 to condense with t-butyl-isoleucine to form the dihydro phenanthride ring via proposed 6--electrocyclic ring closure. However, no electrocyclization was observed although there was indication for the formation of the imine intermediate 33. 10a,12 Successful construction of the hydrated phenanthridine core was achieved by removing the MOM-or BOM-protection of the phenol containing the aldehyde 35 and reaction with t-butyl-isoleucine. Finally, treatment of 35 with TFA gave jadomycin A (Scheme 7).
Scheme 7: Synthesis of jadomycin A
The inability of the intermediate 33a to cyclize was attributed to the steric congestion between the MOM-/BOM-protecting group and the quinone ring. Removal of MOM-/BOMprotecting group led to a favorable H-bonding interaction in 33b which aligns the required 6--electrons in plane for the electrocyclization to form phenanthridine ring 36 (Scheme 8). 9,10a The instability associated with the glycosylated product peculated from the total synthesis of jadomycin B.
Scheme 9: Attempted glycosylation
Since the glycosylated natural product was found to be unstable, they pursued the synthesis of a carbasugar analog of jadomycin B. The 5a-carba-digitoxose (cyclitol) unit was synthesized from D-Quinic acid.
14 Mitsunobu reaction was employed to take advantage of the acidic phenol for installation of the cyclitol unit furnishing 41. To complete the synthesis, they followed the same reaction sequence that they developed for the synthesis of jadomycin A (Scheme 10).
Scheme 10: Carbasugar analog of jadomycin B
In 2013, Yu group reported the synthesis of jadomycin B, S, T and ILEVS1080. 15 Their report features the successful glycosylation strategy employed for the synthesis of jadomycin B as well as structure revision of jadomycin S. They have utilized the same synthetic intermediate 36 and the key 6--electrocyclic ring closure discovered by O'Doherty. 9 However, they could use unprotected isoleucine for the synthesis of jadomycin A (Scheme 11).
Scheme 11: Use of unprotected amino acid Later they have successfully developed a glycosylation method for introduction of sugar moieties to the aglycon (jadomycin A). The method involved a low-temperature Mitsunobu reaction using peracylated glycosyl donor 46 and jadomycin A as the glycosyl acceptor (Scheme 12). This enabled them to complete the total synthesis of jadomycin B and ILEVS1080.
Scheme 12: Successful glycosylation
Yu and coworker found that the proposed aglycon of jadomycin S and T, which contain 4-(hydroxymethyl)-1,3-oxazolidin-5-one moiety, could not be accessed. 15 Instead the corresponding 1,3-oxazolidin-4-carboxylic acid derivative were obtained. Initially sodium O-TBS L-serinate was used to condense with aldehyde 36. As expected, the pentacyclic core of jadomycin 50 was obtained in good yield. However, when TBS-and acetate-protecting groups and were removed in 51, rearrangement of 1,3-oxazolidin-5-one was observed to form 1,3-oxazolidin-4-carboxylic acid (jadomycin S, revised structure). The presence of 1,3-oxazolidin-4-carboxylic acid moiety in jadomycin S was confirmed by synthesis using Lserine allyl ester to condense with aldehyde 36. The pentacyclic core containing the 1,3-oxazolidin-4-allylcarboxylate 11 did not rearrange after deprotection (Scheme 13). The spectral data of the synthetic materials matched with the reported data for jadomycin S. The synthetic effort led by Yu Yu and coworker confirmed the earlier proposed structural revision of jadomycin S by Ishikawa group in 2012. 8 A similar rearrangement of 1,3-oxazolidin-5-one was also observed in the total synthesis of jadomycin T. The synthetic efforts discussed above led to structure revision of several members within jadomycin family as well as provided a platform for the synthesis of natural products and their analogs. Significant progress has also been made for obtaining these materials from natural sources. The ease of incorporating an amino acid (natural or unnatural) 5a,5d,16 during jadomycin biosynthesis has led to several semisynthetic approaches for obtaining novel jadomycin analogs.
In 2012 Jakeman and coworker reported a series of triazole containing jadomycin analogs. 17 The triazole analogs were obtained by a copper catalyzed azide-alkyne cycloaddition (CuAAC) reaction of a jadomycin analog containing terminal alkyne 55 with various azides (Scheme 14). This terminal alkyne containing jadomycin was obtained through biosynthetic pathway using alkyne functionalized amino acid (O-propargyl-Lserene) 54 as sole nitrogen source during fermentation (Scheme 14).
Scheme 14: Jadomycin triazole analogs
The triazole analogs thus obtained were tested for copper dependent DNA damaging experiments.
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Single strand break was observed for all derivatives with equimolar Cu(OAc) 2 while none showed double-strand DNA cleavage. The triazole containing analogs 56 -63 did not show any activity against Gramnegative bacteria, but the terminal alkyne containing analog 55 was active against Gramnegative bacteria. Screening against NCI standard 60 cell-line panel showed that the non-triazole containing analog 55 was the least active illustrating the importance of triazole in cytotoxicity.
In the same year Jakeman group reported the chemo-enzymatic synthesis of jadomycin amide analogs. 18 In the fermentation process, 4-amino-1-phenyl-alanine was used to introduce the amine functionality, which was used for further derivatization. Eleven differently substituted phenyl alanine analogs were investigated but only 4-amino-1-phenyl alanine (both enantiomers) gave appreciable yield. Isolation of the product after fermentation was found to be difficult due to the presence of unprotected aniline moiety. Thus, derivatization was performed on crude material (Scheme 15).
Scheme 15: Jadomycin amide-analogs
Unlike the triazole analogs, 17 jadomycin amide analogs 66 -68 did not induce Cu-mediated DNA cleavage or showed any activity on the standard NCI 60 cell-line panel. Photodynamic inactivation of bacteria was also not observed for these amide analogs.
In 2015 Jakeman group reported isolation of a unique eight-membered ring containing jadomycin (jadomycin oct) 70 from the Streptomyces culture. 19 L-ornithine was used as the amino acid source and the only detectable product in the culture media was jadomycin oct 70. This report is in contrast with the report from Yang group which describes formation of only five-membered ring containing jadomycin using L-ornithine 69 in the culture medium. 20 Chemoselective derivatization was performed with N-hydroxy succinimide activated carboxylic acids 71 to characterize the structure of 70 and for analog synthesis (Scheme 16).
Scheme 16: Jadomycin oct derivatives
Biological analysis of the jadomycin oct analogs showed that the eight-membered analogs (72 -77) are less active then the five-membered jadomycins. Although these analogs mediate Cu-II catalyzed DNA cleavage, cytotoxicity was limited. Analogs 72 -77 exhibited photodynamic inactivation (PDI) of bacteria. This result is interesting because the amide derivatives of five-membered ring containing jadomycin did not show PDI.
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Conclusion:
The total synthetic efforts on jadomycin family of natural products has enabled better understanding of the biosynthetic pathway as well as provided tools for diverse analog synthesis. Amongst many, the notable discoveries include non-natural amino acid incorporation in the biosynthetic pathway, glycosylation of jadomycin A and structural revision of jadomycin S and T. Parallel to the synthetic approaches, the semi-synthetic efforts demonstrate that the jadomycin scaffold is tolerated to chemical modification postbiosynthesis, thus, expanded the scope of jadomycin library synthesis.
